ES449191A1 - Un procedimiento de preparacion de derivados de 4,5,6,7-te- trahidro-tieno-(2,3-c)-piridina. - Google Patents
Un procedimiento de preparacion de derivados de 4,5,6,7-te- trahidro-tieno-(2,3-c)-piridina.Info
- Publication number
- ES449191A1 ES449191A1 ES449191A ES449191A ES449191A1 ES 449191 A1 ES449191 A1 ES 449191A1 ES 449191 A ES449191 A ES 449191A ES 449191 A ES449191 A ES 449191A ES 449191 A1 ES449191 A1 ES 449191A1
- Authority
- ES
- Spain
- Prior art keywords
- chr2
- carbon atoms
- alkyl
- thieno
- composition containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- NQIBQILAMKZKFE-UHFFFAOYSA-N 2-(5-bromo-2-fluorophenyl)-3-fluoropyridine Chemical class FC1=CC=C(Br)C=C1C1=NC=CC=C1F NQIBQILAMKZKFE-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- -1 phenoxy, benzoyl Chemical group 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7520241A FR2315274A1 (fr) | 1975-06-27 | 1975-06-27 | Nouveaux derives de la thieno (2,3-c) pyridine, leur preparation et leurs applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES449191A1 true ES449191A1 (es) | 1977-12-01 |
Family
ID=9157178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES449191A Expired ES449191A1 (es) | 1975-06-27 | 1976-06-25 | Un procedimiento de preparacion de derivados de 4,5,6,7-te- trahidro-tieno-(2,3-c)-piridina. |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4075340A (enExample) |
| JP (1) | JPS607633B2 (enExample) |
| AR (1) | AR211777A1 (enExample) |
| AT (1) | AT347950B (enExample) |
| BE (1) | BE843402A (enExample) |
| CA (1) | CA1071635A (enExample) |
| CH (1) | CH596169A5 (enExample) |
| DD (1) | DD125080A5 (enExample) |
| DE (1) | DE2628045A1 (enExample) |
| DK (1) | DK279976A (enExample) |
| ES (1) | ES449191A1 (enExample) |
| FR (1) | FR2315274A1 (enExample) |
| GB (1) | GB1492239A (enExample) |
| GR (1) | GR60042B (enExample) |
| HU (1) | HU172697B (enExample) |
| IE (1) | IE43915B1 (enExample) |
| IL (1) | IL49702A (enExample) |
| LU (1) | LU75230A1 (enExample) |
| MX (1) | MX3565E (enExample) |
| NL (1) | NL183032C (enExample) |
| PL (1) | PL105962B1 (enExample) |
| PT (1) | PT65271B (enExample) |
| SE (1) | SE421698B (enExample) |
| SU (1) | SU628820A3 (enExample) |
| YU (1) | YU39480B (enExample) |
| ZA (1) | ZA763270B (enExample) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4127580A (en) * | 1975-02-07 | 1978-11-28 | Parcor | Process for the preparation of thieno-pyridine derivatives |
| FR2395271A1 (fr) * | 1977-06-21 | 1979-01-19 | Parcor | Procede de preparation de thieno (2,3-c) et thieno (3,2-c) pyridines |
| US4749692A (en) * | 1977-06-22 | 1988-06-07 | Sanofi, S.A. | Therapeutic compositions having anti-thrombotic and anti-blood-platelet-aggregating activity |
| GB2038625B (en) * | 1978-12-29 | 1983-01-12 | Parcor | Therapeutic composition having an antithrombotic and antiblood-platelet-aggregating activity |
| FR2397417A1 (fr) * | 1977-07-12 | 1979-02-09 | Parcor | Procede de preparation de derives de la thienopyridine |
| AT368504B (de) * | 1977-10-15 | 1982-10-25 | Boehringer Sohn Ingelheim | Verfahren zur herstellung neuer 4-phenyl-thieno- (2,3-c)-piperidine |
| US4321266A (en) * | 1980-10-06 | 1982-03-23 | Sanofi | 5-o-Cyanobenzyl-4,5,6,7-tetrahydrothieno [3,2-C] pyridine |
| FR2508453A1 (fr) * | 1981-06-30 | 1982-12-31 | Sanofi Sa | Procede de preparation de derives des (thienyl-2)- et thienyl-3)-2 ethylamines et produits ainsi obtenus |
| US4547514A (en) * | 1983-12-05 | 1985-10-15 | A. H. Robins Company, Incorporated | Aryloxy-N-(aminoalkyl)-1-pyrrolidine and piperidine carboxamides and carbothioamides having antiarrhythmic activity |
| DE3736664A1 (de) * | 1987-10-29 | 1989-05-11 | Boehringer Ingelheim Kg | Tetrahydro-furo- und -thieno(2,3-c)pyridine, ihre verwendung als arzneimittel und verfahren zu ihrer herstellung |
| US5294621A (en) * | 1992-10-07 | 1994-03-15 | Ortho Pharmaceutical Corporation | Thieno tetrahydropyridines useful as class III antiarrhythmic agents |
| AU4698299A (en) | 1998-06-30 | 2000-01-17 | Du Pont Pharmaceuticals Company | 5-HT7 receptor antagonists |
| AU5154699A (en) * | 1998-09-02 | 2000-03-27 | Novo Nordisk A/S | 4,5,6,7-tetrahydro-thieno(2,3-c)pyridine derivatives |
| US6090797A (en) * | 1998-09-02 | 2000-07-18 | Novo Nordisk A/S | 4,5,6,7-tetrahydro-thieno(2,3-C)pyridine derivatives |
| US8914114B2 (en) | 2000-05-23 | 2014-12-16 | The Feinstein Institute For Medical Research | Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
| JP2005522457A (ja) * | 2002-02-26 | 2005-07-28 | ノース ショア−ロング アイランド ジューイッシュ リサーチ インスティチュート | 脳ムスカリン性レセプターの刺激による炎症性サイトカイン産生の阻害 |
| US10912712B2 (en) | 2004-03-25 | 2021-02-09 | The Feinstein Institutes For Medical Research | Treatment of bleeding by non-invasive stimulation |
| JP2007530586A (ja) | 2004-03-25 | 2007-11-01 | ザ ファインスタイン インスティテュート フォー メディカル リサーチ | 神経性止血法 |
| CA2593079C (en) | 2004-12-27 | 2014-08-19 | North Shore-Long Island Jewish Research Institute | Treating inflammatory disorders by electrical vagus nerve stimulation |
| US11207518B2 (en) | 2004-12-27 | 2021-12-28 | The Feinstein Institutes For Medical Research | Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway |
| WO2009029614A1 (en) | 2007-08-27 | 2009-03-05 | The Feinstein Institute For Medical Research | Devices and methods for inhibiting granulocyte activation by neural stimulation |
| US9662490B2 (en) | 2008-03-31 | 2017-05-30 | The Feinstein Institute For Medical Research | Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug |
| US9211409B2 (en) | 2008-03-31 | 2015-12-15 | The Feinstein Institute For Medical Research | Methods and systems for reducing inflammation by neuromodulation of T-cell activity |
| US8412338B2 (en) | 2008-11-18 | 2013-04-02 | Setpoint Medical Corporation | Devices and methods for optimizing electrode placement for anti-inflamatory stimulation |
| US9211410B2 (en) | 2009-05-01 | 2015-12-15 | Setpoint Medical Corporation | Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation |
| US8996116B2 (en) | 2009-10-30 | 2015-03-31 | Setpoint Medical Corporation | Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction |
| EP2440284B1 (en) | 2009-06-09 | 2018-09-12 | Setpoint Medical Corporation | Nerve cuff with pocket for leadless stimulator |
| US9833621B2 (en) | 2011-09-23 | 2017-12-05 | Setpoint Medical Corporation | Modulation of sirtuins by vagus nerve stimulation |
| US11051744B2 (en) | 2009-11-17 | 2021-07-06 | Setpoint Medical Corporation | Closed-loop vagus nerve stimulation |
| WO2011079309A2 (en) | 2009-12-23 | 2011-06-30 | Setpoint Medical Corporation | Neural stimulation devices and systems for treatment of chronic inflammation |
| US12172017B2 (en) | 2011-05-09 | 2024-12-24 | Setpoint Medical Corporation | Vagus nerve stimulation to treat neurodegenerative disorders |
| CN103619405B (zh) | 2011-05-09 | 2015-11-25 | 赛博恩特医疗器械公司 | 用于治疗慢性炎症的胆碱能抗炎通路的单个脉冲激活 |
| CN104364257B (zh) | 2012-03-23 | 2017-03-01 | 纪念斯隆-凯特琳癌症中心 | 5‑酰基‑6,7‑二氢噻吩并[3,2‑c]吡啶类化合物对胰腺及相关癌症的治疗作用 |
| US9572983B2 (en) | 2012-03-26 | 2017-02-21 | Setpoint Medical Corporation | Devices and methods for modulation of bone erosion |
| WO2016018701A1 (en) | 2014-07-28 | 2016-02-04 | Merck Sharp & Dohme Corp. | FACTOR XIa INHIBITORS |
| US11311725B2 (en) | 2014-10-24 | 2022-04-26 | Setpoint Medical Corporation | Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation |
| WO2016126807A1 (en) | 2015-02-03 | 2016-08-11 | Setpoint Medical Corporation | Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator |
| US10596367B2 (en) | 2016-01-13 | 2020-03-24 | Setpoint Medical Corporation | Systems and methods for establishing a nerve block |
| WO2017127756A1 (en) | 2016-01-20 | 2017-07-27 | Setpoint Medical Corporation | Control of vagal stimulation |
| EP3405255A4 (en) | 2016-01-20 | 2019-10-16 | Setpoint Medical Corporation | IMPLANTABLE MICROSTIMULATORS AND INDUCTIVE CHARGING SYSTEMS |
| US11471681B2 (en) | 2016-01-20 | 2022-10-18 | Setpoint Medical Corporation | Batteryless implantable microstimulators |
| US10583304B2 (en) | 2016-01-25 | 2020-03-10 | Setpoint Medical Corporation | Implantable neurostimulator having power control and thermal regulation and methods of use |
| EP3668402B1 (en) | 2017-08-14 | 2024-07-31 | Setpoint Medical Corporation | Vagus nerve stimulation pre-screening test |
| US11260229B2 (en) | 2018-09-25 | 2022-03-01 | The Feinstein Institutes For Medical Research | Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation |
| EP3952982B1 (en) | 2019-04-12 | 2024-03-27 | Setpoint Medical Corporation | Vagus nerve stimulation system to treat neurodegenerative disorders |
| US11938324B2 (en) | 2020-05-21 | 2024-03-26 | The Feinstein Institutes For Medical Research | Systems and methods for vagus nerve stimulation |
| US12444497B2 (en) | 2021-05-17 | 2025-10-14 | Setpoint Medical Corporation | Neurostimulation parameter authentication and expiration system for neurostimulation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2215948B1 (enExample) * | 1973-02-01 | 1976-05-14 | Centre Etd Ind Pharma |
-
1975
- 1975-06-27 FR FR7520241A patent/FR2315274A1/fr active Granted
-
1976
- 1976-05-17 CH CH612276A patent/CH596169A5/xx not_active IP Right Cessation
- 1976-05-31 IE IE1149/76A patent/IE43915B1/en unknown
- 1976-06-01 IL IL49702A patent/IL49702A/xx unknown
- 1976-06-01 GR GR50863A patent/GR60042B/el unknown
- 1976-06-02 ZA ZA763270A patent/ZA763270B/xx unknown
- 1976-06-02 US US05/692,186 patent/US4075340A/en not_active Expired - Lifetime
- 1976-06-14 SU SU762367256A patent/SU628820A3/ru active
- 1976-06-15 YU YU1462/76A patent/YU39480B/xx unknown
- 1976-06-17 NL NLAANVRAGE7606574,A patent/NL183032C/xx not_active IP Right Cessation
- 1976-06-21 CA CA255,299A patent/CA1071635A/en not_active Expired
- 1976-06-22 DK DK279976A patent/DK279976A/da unknown
- 1976-06-23 SE SE7607201A patent/SE421698B/xx not_active IP Right Cessation
- 1976-06-23 DE DE19762628045 patent/DE2628045A1/de not_active Ceased
- 1976-06-24 AT AT461776A patent/AT347950B/de not_active IP Right Cessation
- 1976-06-24 LU LU75230A patent/LU75230A1/xx unknown
- 1976-06-24 PT PT65271A patent/PT65271B/pt unknown
- 1976-06-24 AR AR263737A patent/AR211777A1/es active
- 1976-06-25 BE BE168304A patent/BE843402A/xx not_active IP Right Cessation
- 1976-06-25 GB GB26591/76A patent/GB1492239A/en not_active Expired
- 1976-06-25 ES ES449191A patent/ES449191A1/es not_active Expired
- 1976-06-25 DD DD193581A patent/DD125080A5/xx unknown
- 1976-06-25 MX MX76799U patent/MX3565E/es unknown
- 1976-06-25 HU HU76PA00001254A patent/HU172697B/hu not_active IP Right Cessation
- 1976-06-26 JP JP51075943A patent/JPS607633B2/ja not_active Expired
- 1976-06-26 PL PL1976190741A patent/PL105962B1/pl unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES449191A1 (es) | Un procedimiento de preparacion de derivados de 4,5,6,7-te- trahidro-tieno-(2,3-c)-piridina. | |
| DK584886A (da) | Vanduoploeselige, mono- og disubstituerede derivater af rapamycin og farmaceutisk acceptable salte deraf | |
| YU64092A (sh) | Fluoralkoksibenzamino derivati heterocikličnih jedinjenja koja sadrže azot | |
| ES8506629A1 (es) | Un procedimiento para preparar derivados de piridina | |
| MY103905A (en) | Aminoalkoxyphenyl derivatives, process of preparation and compositions containing the same. | |
| ES2000312A6 (es) | Un procedimiento para preparar derivados de dihidroperidaazinona | |
| NO971376L (no) | N-substituerte piperidinyl bisykliske benzoatderivater | |
| ES311444A1 (es) | Procedimiento para la obtencion de compuestos piridinicos. | |
| GR75618B (enExample) | ||
| ES8701762A1 (es) | Un procedimiento para preparar nuevos derivados de 5-(w-fe- netilamino-alquil)-4,5,6,7-tetrahidro-tieno-(3,2-c)-piridina | |
| ES447495A1 (es) | Un procedimiento de preparacion de derivados de tetrahidro- 4, 5, 6, 7-tieno-(3, 2-c)-piridina. | |
| ES8306099A1 (es) | Un procedimiento para la preparacion de derivados de acido 2-(2-cianoetil)-2-benzoilamino-alcanoicos. | |
| ES8207181A1 (es) | Procedimiento para la fabricacion de derivados de 5,6,7,7atetrahidro-4h-tieno(3,2-c)-piridin-2-ona . | |
| ES459705A1 (es) | Procedimiento para la preparacion de derivados de hidracina-piridacina. | |
| ES455023A1 (es) | Procedimiento para preparar derivados de tieno-(3, 2-c)-pi- ridina. | |
| ES451655A1 (es) | Un procedimiento para la preparacion de derivados de pirimi-dina. | |
| ES485302A1 (es) | Procedimiento para la preparacion de halogenosulfamoilbence-nos | |
| ES2006336A6 (es) | Procedimiento de preparacion de nuevas acetamidas derivadas de la 2,3-dihidro-3-fenil-2-benzofuranona. | |
| ES445477A1 (es) | Procedimiento para preparar derivados de guanidina. | |
| ES457996A1 (es) | Un procedimiento para la preparacion de nuevos derivados de morfolina. | |
| ES438056A3 (es) | Procedimiento para la preparacion de nuevos derivados de a- cidos carboxilicos ciclicos. | |
| ES472090A2 (es) | Mejoras introducidas en el objeto de la patente principal n.451407 por:procedimiento para preparar derivados de amidoxi-ma | |
| JO1047B1 (en) | Vehicles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19981001 |